Browsing by Subject "Alzheimer’s disease"
Now showing items 1-14 of 14
-
An ambient assisted living system for Alzheimer’s patients
(Brac University, 2022-09)Alzheimer’s is a brain disorder that gradually deteriorates the brain functions of the patients. As the disease progresses, victims start to lose their memory, thinking ability, eventually rendering them unable to perform ... -
Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
(Brac University, 2022-03)Alzheimer's disease is a fatal illness that primarily affects older generations; its pathology pathways include beta-amyloid, tau protein, and activated microglia, destruction of synapse and no disease-modifying medication ... -
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
(Brac University, 2022-04)A decade has passed since no new Alzheimer's disease (AD) therapies were approved, even though it is the leading motive of dementia in the modern era. The community of patients with AD leads to expansion. Anxiety, anger, ... -
Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
(Brac University, 2021-09)Alzheimer’s Disease (AD) is a neurological condition where the decline of brain cells causes acute memory loss and severe loss in cognitive functionalities. Various Neuroimaging techniques have been developed to diagnose ... -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
(Brac University, 2022-10-30)Rivastigmine is an anti-cholinesterase agent, used to treat mild to moderate dementia of Alzheimer’s disease (AD). Its efficacy and tolerability increase the treatment compliance. This study focused on determining the ... -
Emerging therapies of Alzheimer’s disease: a comprehensive review
(Brac University, 2022-11)Alzheimer’s disease is a complex, debilitating neurodegenerative disorder, with a rapidly increasing worldwide prevalence. Despite decades of intense research, therapeutics for Alzheimer's disease are still limited to ... -
Epigenetic dysregulation in neurodegenerative diseases and potential treatment
(Brac University, 2022-04)Epigenetics holds significant relevance in the contemporary neuroscience and has been associated with the pathogenesis of different neurodegenerative disorders. Epigenetic modifications including DNA methylation and histone ... -
Glymphatic system: a pathway for managing endogenous metabolites in CNS
(Brac University, 2017-11)Glymphatic pathway is one of the recent discoveries of neuro pharmacology which is a brainwide paravascular system to exchange cerebrospinal fluid (CSF) and interstitial fluid. This system is associated with the clearance ... -
Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
(Brac University, 2022-04)Purpose: Alzheimer's disease (AD) is a multifactorial neurodegenerative brain disorder that affects approximately 5.3 million people in the United States, including nearly half of the population aged 85 and up. It has ... -
Marine compounds in the treatment of Alzheimer’s disease
(Brac University, 2022-03)Brain shrinkage and cell death occurs due to Alzheimer's disease, a degenerative neurologic illness. Memory loss, social and behavioral deterioration, and the inability to operate independently are all symptoms of Alzheimer's ... -
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
(Brac University, 2019-05)Alzheimer’s disease is one of leading diseases which provokes different internal physiological conditions that ease deterioration of normal body mechanism among people over 60 years of age. The proper pathophysiology of ... -
Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
(Brac University, 2021-11)Tau protein is one of the keystones in the diagnosis of Alzheimer’s disease. The modern detection techniques have come up to visualize, track and assess tau pathology and have further contributed with information about tau ... -
A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
(BRAC University, 2018-08)Alzheimer’s disease (AD), a deadly neurodegenerative disease, which is considered as one of the top causes of death for people who are over 65 years of age. Up until now, no drug has been developed that can cure this disease ... -
Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
(Brac University, 2022-11)In neurology, Alzheimer's disease represents greatest unmet medical need. Formation of neurofibrillary tangles, Amyloid Beta-peptide (Aβ) deposition, and significant oxidative stress, synapse loss are features of the ...
